Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure

Jonathan Uy*, Carl Armon, Kate Buchacz, Kathy Wood, John T. Brooks, J. T.B. Kb, Tony Tong, Anne Moorman, Kathleen C. Wood, Rose K. Baker, James T. Richardson, Darlene Hankerson, Frank J. Palella, Joan S. Chmiel, Aditya Chawla, Onyinye Enyia, Kenneth A. Lichtenstein, Cheryl Stewart, John Hammer, Benjamin YoungKenneth S. Greenberg, Barbara Widick, Joslyn D. Axinn, Bienvenido G. Yangco, Kalliope Halkias, Douglas J. Ward, Charles A. Fiorentino, Jack Fuhrer, Linda Ording-Bauer, Rita Kelly, Jane Esteves, Ellen M. Tedaldi, Ramona A. Christian, Faye Ruley, Atiya Nimmons, Richard M. Novak, Andrea Wendrow

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure'. Together they form a unique fingerprint.

Medicine & Life Sciences